To verify the increasing expression of PHGDH in GSCs, we performed immunoblot (IB) and qRT-PCR analyses of several GSCs and differentiated GBM cells (DGCs), which were derived from GBM patients or patient-derived xenografts (PDXs), as previously described [21, 25–27]. This evidence concerns the gene PHGDH and glioblastoma.